The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Reactive oxygen species: a volatile driver of field cancerization and metastasis
Open accessAbstract
Field cancerization and metastasis are the leading causes for cancer recurrence and mortality in cancer patients. The formation of primary, secondary tumors or metastasis is greatly influenced by multifaceted tumor-stroma interactions, in which stromal components of the tumor microenvironment (TME) can affect the behavior of the cancer cells. Many studies have identified cytokines and growth factors as cell signaling molecules that aid cell to cell communication. However, the functional contribution of reactive oxygen species (ROS), a family of volatile chemicals, as communication molecules are less understood. Cancer cells and various tumor-associated stromal cells produce and secrete a copious amount of ROS into the TME. Intracellular ROS modulate cell signaling cascades that aid in the acquisition of several hallmarks of cancers. Extracellular ROS help to propagate, amplify, and effectively create a mutagenic and oncogenic field which facilitate the formation of multifoci tumors and act as a springboard for metastatic tumor cells. In this review, we summarize our current knowledge of ROS as atypical paracrine signaling molecules for field cancerization and metastasis. Field cancerization and metastasis are often discussed separately; we offer a model that placed these events with ROS as the focal instigating agent in a broader "seed-soil" hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oxidative stress is strongly associated with the expression of various inflammatory transcription factors, such as nuclear factor-kB (NF- kB) that modulates proteolytic pathways and promotes inflammation (29–31).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [31]
In the citing paper
“Cancer is a class of diseases resulted from external factors such as environment, diet and radiation as well as internal factors including obesity and diabetes (31, 116, 117).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
NF-κB signaling in inflammation
Liu, T., Zhang, L., Joo, D., & Sun, S.-C. (2017) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2017.23 · Cited by 8,791
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Slaughter, D. P., Southwick, H. W., & Smejkal, W. (1953) · Cancer · doi:10.1002/1097-0142(195309)6:5 · Cited by 3,558
Cited by
Sorted by citations
Items 201–282 of 282
CD44 and RHAMM Are Microenvironmental Sensors with Dual Metastasis Promoter and Suppressor Functions
Tölg, C., Hill, K. A., & Turley, E. A. (2024) · Advanced Biology · doi:10.1002/adbi.202300693 · Cited by 2
Kenanoğlu, S., Akalın, H., Aslan, D., İnanç, M., Öztürk, F., & Dündar, M. (2024) · Gene Reports · doi:10.1016/j.genrep.2024.102020 · Cited by 2
ROS‐Activatable Prodrug of Doxazolidine as Novel Cancer Therapy Paradigm
Tamura, R., Carpenter, C. I., Thomas, C. M., Kamyabi, G., Hsu, H., Vergnolle, O., Balderes, P. J., & Grimm, J. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400340 · Cited by 2
ROS Modulatory Role of HDAC Inhibitors in Cancer Cells
Ramaiah, M. J., Ramalingam, P. S., Moparthi, N. R., & Kutala, V. K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_250-1 · Cited by 2
A systematic review of genes affecting mitochondrial processes in cancer
Sepúlveda-Villegas, M., Rojo, R., Garza-Hernandez, D., de la Rosa-Garza, M., & Treviño, V. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165846 · Cited by 3
How Oncogenic Viruses Exploit p62-Mediated Selective Autophagy for Cancer Development
Wang, L. (2021) · Annals of Immunology & Immunotherapy · doi:10.23880/aii-16000134 · Cited by 1
Bhattacharjee, S., Paul, S., & Raybarman, C. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_152 · Cited by 2
Kit, O. I., Frantsiyants, E. M., Goroshinskaya, I. A., Kaplieva, I. V., Shikhlyarova, A. I., Nemashkalova, L. A., Trepitaki, L. K., Kachesova, P. S., Владимировна, Б. О., Владимировна, С. Е., et al. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.21.2733 · Cited by 2
ROS, Redox Regulation and Signaling in Cancer Cells
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_1 · Cited by 1
Wang, C., Li, M.-C., Huang, S., Huang, W., He, T., Wusiman, M., Zhu, H., & Liu, Z. (2024) · Food Frontiers · doi:10.1002/fft2.489 · Cited by 1
Zhao, Y., Kong, W., Zhu, J., & Qu, F. (2024) · Chemical Science · doi:10.1039/d4sc06305h · Cited by 1
Jia, C., Luo, D., Zhou, J., Xie, X., Lam, H. Y. I., Li, P., Mu, Y., Zeng, Z., & Ren, C. (2024) · Angewandte Chemie · doi:10.1002/ange.202419800 · Cited by 1
Liu, Y., Lan, X., Zhang, X., Ren, X., Duan, H., Dan, Y. R., Duan, D., & Lu, G. (2025) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2025.100385 · Cited by 1
Alghzzawy, Z. M., Awwad, M. H., Elmaghraby, T. K., Hagag, S. A. E.-H., Kayed, A. E., & Ibrahim, D. S. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500453 · Cited by 1
Lu, D., Li, X., Zeng, X., Yuan, L., & Li, J. (2026) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2026.186146 · Cited by 1
Mahata, R., & Choudhury, S. M. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04933-y · Cited by 1
Li, J., Ying, R., Luo, J., Guo, X., & Zhang, M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340976 · Cited by 1
Ferreira, R. O. G., Çanga, E. M., Gowen, A., McMorrow, T., & Xu, J. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102285 · Cited by 1
On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer
Nikiforova, A. B. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156887 · Cited by 1
Reactive Oxygen Species in Stem Cell Proliferation and Cancer
Verma, Y. K., Kumar, S., Tyagi, N., & Gangenahalli, G. U. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_118-1 · Cited by 1
Reactive Oxygen Species Mediated Cancer Progression and Metastasis
Chugh, N., & Koul, A. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_160-1 · Cited by 1
Goroshinskaya, I. A., Frantsiyants, E. M., Kaplieva, I. V., Nemashkalova, L. A., Trepitaki, L. K., Kachesova, P. S., Surikova, E. I., Bandovkina, V. A., Игоревна, М. М., Котиева, И. М., et al. (2021) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2021-4-153-167 · Cited by 1
Non-coding RNAS as Trojan Horse in Eliminating ROS Induced Cancer
Shaw, S., Khurana, S., Nayak, R., & Bose, S. K. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_80-1 · Cited by 1
Debnath, S. K., Singh, B., Agrawal, N., & Srivastava, R. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_127-1 · Cited by 1
Nanostructured Lipid Carriers: New Insight for Cancer Therapy
Jiwankar, M. N., & Sabale, V. (2022) · Nanoscience & Nanotechnology-Asia · doi:10.2174/2210681212666220523123316 · Cited by 1
Zeliger, H. I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91890-9.00036-2 · Cited by 2
Anti-Cancer Activities of Natural Products
Giri, N. C., Patro, B. P., & Verma, V. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-0703-8.ch004 · Cited by 1
Frontier advances on biomechanical therapies
Chakraborty, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-90597-8.00013-x · Cited by 2
Tumanyan, S. V., Goroshinskaya, I. A., Kaplieva, I. V., Verenikina, E. V., Ушакова, Н. Д., & Alnikin, A. B. (2023) · Pirogov Russian Journal of Surgery · doi:10.17116/hirurgia202309159 · Cited by 1
Cancer Metastasis, ROS/Redox Signaling, and PCD Resistance/Redox Metabolism
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_5 · Cited by 1
Zelenskyi, Е. А., Rutto, K. V., Trulioff, A. S., Magazenkova, D. N., Av, S., & Kisseleva, E. P. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093024040240 · Cited by 1
Role of Macrophages in Oxidative Stress Induced Inflammatory Tumor Microenvironment
Teli, A., Kshirsagar, D., Doshi, S., & Dey, T. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_61-1 · Cited by 1
Reactive Oxygen Species–Mediated Cancer Progression and Metastasis
Chugh, N., & Koul, A. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_160 · Cited by 1
ROS-Mediated Inflammatory Response in Cancer
Muralidar, S., Gopal, G., & Ambi, S. V. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_181 · Cited by 1
Reactive Oxygen Species in Stem Cell Proliferation and Cancer
Verma, Y. K., Kumar, S., Tyagi, N., & Gangenahalli, G. U. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_118 · Cited by 1
Redox status of blood lymphocytes in patients with soft tissue sarcomas
Goroshinskaya, I. A., Kaplieva, I. V., Frantsiyants, E. M., Vashchenko, L. N., Kachesova, P. S., Lapteva, T. O., Ausheva, T. V., Nemashkalova, L. A., Trepitaki, L. K., & Pandova, O. V. (2023) · Bone and soft tissue sarcomas tumors of the skin · doi:10.17650/2782-3687-2023-15-3-21-33 · Cited by 1
Kit, O. I., Goroshinskaya, I. A., Frantsiyants, E. M., Kharagezov, D. A., Nemashkalova, L. A., Lazutin, Y. N., Milakin, A. G., Leyman, I. A., Stateshny, O. N., & Pandova, O. V. (2023) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2023-4-73-87 · Cited by 1
Radharani, N. N. V., Kundu, I. G., Yadav, A. S., & Kundu, G. C. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_164-1
ROS-Mediated Inflammatory Response in Cancer
Muralidar, S., Gopal, G., & Ambi, S. V. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_181-1
Recent Interpretations of the CPLR by New York Appellate Courts
Goldberg, B. D., & Montes, R. J. (2011) · Albany law review
Application of Bioinformatics Databases in the Study of Oxidative Stress Related Cancers
Bagchi, A., & Bhagat, G. K. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_141-1
Role of ROS-Mediated Epigenetic Alterations in the Development of Solid Tumor
Chattopadhyay, I. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_81-1
Bhattacharjee, S., Paul, S., & Raybarman, C. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_152-1
Badid, N., Merzouk, H., & Charef, A. (2021) · Electronic physician · doi:10.19082/7822
Radharani, N. N. V., Kundu, I. G., Yadav, A. S., & Kundu, G. C. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_164
Role of Macrophages in Oxidative Stress-Induced Inflammatory Tumor Microenvironment
Teli, A., Kshirsagar, D., Doshi, S., & Dey, T. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_61
Reactive Oxygen Species and Cancer Stem Cells
Chengizkhan, G., Sukumar, K., Kunnumakkara, A. B., Queimado, L., Munirajan, A. K., Bhaskaran, R. S., Kumaran, R., & Ramachandran, I. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_109-1
Targeting Reactive Oxygen Species (ROS) for Cancer Therapy
Mohan, H., Vandna, V., Soni, S., & Syed, S. M. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_273-1 · Cited by 1
Chengizkhan, G., Sukumar, K., Kunnumakkara, A. B., Queimado, L., Munirajan, A. K., Bhaskaran, R. S., Ramachandran, I., & Kumaran, R. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_109-2
Jang, J., Cho, E. H., Cho, Y., Ganzorig, B., Kim, K. Y., Kim, M. G., & Kim, C. (2022) · Molecules and Cells · doi:10.14348/molcells.2022.2004
ROS are evolutionary conserved cell-to-cell signalsPreprint
Fichman, Y., Rowland, L. M., Oliver, M. J., & Mittler, R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.19.504606
Materiobiological Effects Regulate the Bone Microenvironment
Chen, S. (2022) · Wiley eBooks · doi:10.1002/9783527837823.ch2
Regenerative Medicines for ROS-Induced Cancers Treatment
Kumar, D., Ishaque, M., & Raghav, P. K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_97
Role of ROS-Mediated Epigenetic Alterations in the Development of Solid Tumor
Chattopadhyay, I. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_81
Application of Bioinformatics Databases in the Study of Oxidative Stress Related Cancers
Bagchi, A., & Bhagat, G. K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_141
Targeting Reactive Oxygen Species (ROS) for Cancer Therapy
Mohan, H., Vandna, V., Soni, S., & Syed, S. M. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_273
Non-coding RNAs as Trojan Horse in Eliminating ROS-Induced Cancer
Shaw, S., Khurana, S., Nayak, R., & Bose, S. K. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_80
HIF-1α gene/protein and oxidative stress in patients with colorectal cancer: A pilot study
Akbar, S., Fazeli, M. S., Hemmati, R., Pirzadeh, M., Seyedan, S. M., Ferns, G. A., Pakzad, R., Yazdanian, Z., & Mobarra, N. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101783
Chengizkhan, G., Sukumar, K., Kunnumakkara, A. B., Queimado, L., Munirajan, A. K., Bhaskaran, R. S., Kumaran, R., & Ramachandran, I. (2023) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_109-3
Perspectives in ROS/Redox Regulation Cancer Therapy
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_10
Mechanoregulation of angiopoietin-like 4 in epithelial-mesenchymal transition and cancer metastasis
Liao, Z. (2023) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/173585
Self-citationGoroshinskaya, I. A., Frantsiyants, E. M., Ивановна, Л. Н., Przhedetskiy, Y. V., Kaplieva, I. V., Nemashkalova, L. A., Bandovkina, V. A., Pozdnyakova, V. V., & Przhedetskaya, V. Y. (2024) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2024-11-2-2
LAI, Z., ZHAO, H., & Deng, H. X. (2024) · Biocell · doi:10.32604/biocell.2024.053983
Zelenskyi, Е. А., Rutto, K. V., Trulioff, A. S., Magazenkova, D. N., Av, S., & Kisseleva, E. P. (2024) · Российский физиологический журнал им И М Сеченова · doi:10.31857/s0869813924070057
Reactive oxygen species (ROS) and early stage of cancer (Cancer development)
Ždralević, M., & Vučetić, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00003-8
Reactive oxygen species (ROS) and late-stage cancer (Cancer metastasis)
Krajnović, M., Jovanović-Ćupić, S., Kožik, B., & Božović, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-27333-9.00011-7
Брониславовна, М. Е., Евгеньевна, С. А., Romakh, L. P., Петрова, Е. С., Валерьевна, Х. М., Владимирович, Ч. А., Oleynik, A. S., & Кандалинцева, Н. В. (2025) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20250518
Chen, J., Zeng, J., Zhang, Q., Gao, J., & Zhang, F. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/7325445
Tamura, R., & Grimm, J. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01101
Tölg, C., Milojevic, M., Qi, F. W., Pavanel, H. A., Locke, M. E. O., Ma, J., Price, M., Nelson, A. C., McCarthy, J. B., Hill, K. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26599043
Tölg, C., Milojevic, M., Qi, F. W., Pavanel, H. A., Locke, M. E. O., Ma, J., Price, M., Nelson, A. C., McCarthy, J. B., Hill, K. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26599046
Lu, D., Zeng, X., Yuan, L., & Li, J. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5736213
Metabolic crossroads: Integrating ROS, SCF, and gut microbiota in cancer
Parihar, B. O., Kumar, A., & Yadav, A. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00011-9
Брониславовна, М. Е., Евгеньевна, С. А., Romakh, L. P., Петрова, Е. С., Валерьевна, Х. М., Chechushkov, A. V., Oleynik, A. S., & Кандалинцева, Н. В. (2026) · Cell and Tissue Biology · doi:10.1134/s1990519x26020069
Sajeev, S., George, A. R., Thangasamy, K., & Natesan, G. (2026) · Results in Engineering · doi:10.1016/j.rineng.2026.109696
The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment
Govindarajan, R. K., Prathiviraj, R., Waheeb, M. Q., Al-Duais, M. A., Asmari, A., Panneerselvam, C., Rzhepakovsky, I. V., Povetkin, S., & Dahms, H.-U. (2026) · Current Cancer Drug Targets · doi:10.2174/0115680096423510251031065737
Nanoparticles for autoimmune diseases: advancing diagnostics and therapeutic solutions
Ong, E. X. N., Ng, C. Y. J., Cao, L.-L., Li, X., Li, P. P., Tan, N. S., Liao, Z., & Zhao, Y. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01794-w · Cited by 2
Self-citationQiao, K., Huang, Y., Chua, D., Qu, J., Liao, Q., Wang, G., Tan, N. S., Liao, S., Li, L., & Zhang, G. (2026) · Molecular Therapy Oncology · doi:10.1016/j.omton.2026.201251
Self-citationFiorino, S., Hong, W., de Biase, D., Mastrangelo, L., Maccioni, F., Grottesi, A., Ambrosi, F., Pincigher, L., Lari, F., Bergamini, C., et al. (2026) · Cancers · doi:10.3390/cancers18121932
Crosstalk between mitophagy and metabolism in cancer: Mechanisms and therapeutic opportunities
Cheng, J., Xiao, T., Tang, Z., & Chen, Y. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.08.004 · Cited by 1
Pharmacological Potential of Selenoproteins in the Regulation of Oxidative Stress in Liver Diseases
Varlamova, E. G. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18091167
Chromosomal instability in cancer: sources, consequences and new therapeutic opportunities
Serpico, A. F., & Grieco, D. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02940-w
Metadata
- Authors
- Liao, Z., Chua, D., & Tan, N. S.
- Affiliations
- Nanyang Technological University (SG)
- Corresponding author
- Tan, Nguan Soon
- Venue
- Molecular Cancer
- Published
- 2019-03-30
- Volume
- 18
- Issue
- 1
- Pages
- 65-65
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC6441160
- OpenAlex
- W2943576188
- Cited by
- 284
- References
- 106
- Citations by year
- 2026: 18 · 2025: 34 · 2024: 38 · 2023: 42 · 2022: 60 · 2021: 51 · 2020: 32 · 2019: 8
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DR-NTU (Nanyang Technological University) (submittedVersion, cc-by)
- Funders
- Ministry of Education, Singapore (2014-T2-1-012, 2017-T1-002-103)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- reactive oxygen species, field cancerization, metastasis, tumor microenvironment, tumor-stroma interactions, paracrine signaling, multifocal tumors, cancer hallmarks, cytokines and growth factors
- MeSH terms
- Animals, Cell Communication, Humans, Neoplasm Metastasis, Neoplasms, Signal Transduction, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review